Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
University of California, Berkeley · NCT06947187
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 472
- US sites recruiting
- 1
- Study start
- December 28, 2024
- Record last updated
- April 27, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to understand how well a culturally-specific "prebunking" video can improve vaccine information literacy and vaccine confidence among individuals in the Nusantara sociocultural sphere. The investigators hypothesize the individuals who watch the co-created "prebunking" intervention video will have improved vaccine literacy skills and vaccine confidence compared to individuals who watch a video about safe medication disposal.
Being studied: Pre-bunking video; Video on safe disposal of medication
Conditions: Misinformation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- At least 18 years old
- Live in Brunei, Indonesia, Malaysia, or Singapore
- Fluent in Bahasa Melayu or Bahasa Indonesia
- Watch social media content in Bahasa Melayu or Bahasa Indonesia every day
- Access to stable Internet on smartphone or laptop to complete the experiment without interruption
Exclusion Criteria
- Individuals who were involved in the online human-centered design thinking workshops or the in-person focus-group discussions will not be eligible to participate in RCT. This exclusion criterion is put in place to prevent potential bias in the evaluation of the intervention's effectiveness.
- Individuals who have difficulty in looking at social media on cellphone (even when they use prescription glasses), listening to the audio of social media content on cellphone (even with hearing aid), and typing within or engaging with social media content on cell phone are not eligible to participate in this study. -
Recruiting US locations
University of California, Berkeley
Berkeley, CA 94720
Site contact: Laura H Kwong, PhD · 650-460-9593 · lakwong@berkeley.edu
Study contacts (from the official record)
- Laura H Kwong, PhD · +1-650-332-4667 · lakwong@berkeley.edu
Similar studies in California
All vaccine studies in California →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- La Mesa, CA + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Huntington Beach, CA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Madera, CA + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1/Phase 2
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Sanofi
- Location
- Rolling Hills Estates, CA + 15 other US sites
- Eligibility basics
- Ages 18+